The outstanding core technology of niche nanomedicine, iron oxide nanoparticles developed by “MegaPro Biomedical”, a biotechnology start-up by ITRI, as well as the future nano-micelle drug carrier received the Start-up Award in the 13th National Innovation Award. After its spin-off from ITRI in 2015, the team in MegaPro Biomedical has been actively developing iron oxide nanoparticle injection (IOP Injection). With a three-staged review, the judges from the Institute for Biotechnology and Medicine Industry believed that the niche nanomedicine, iron oxide nanoparticle, has the potential for development. MegaPro Biomedical has a firm technology foundation and the core technology for the future development of nano-micelle drug carrier is also clear. As a result, the Institute for Biotechnology and Medicine Industry awarded MegaPro Biomedical the Start-up Award in the 13th National Innovation Award to affirm its excellent performance hitherto and development potential.